Use of biochemical testing technologies in the medical industry has aided the growth of the global automated immunoassay analyzers market. The relevance of conducting diagnostic tests in the healthcare industry cannot be underestimated. Several sub-domains within healthcare have invested in developing sound and effective diagnostic tests. Furthermore, these sub-domains have also been involved in sampling and analysis of substances used for medical analysis. The recent uptick in revenues caused across the field of clinical research has given an impetus to the growth of the global automated immunoassay analyzers market. Therefore, it is safe to state that hospitals and clinical laboratories are the primary consumers within the global immunoassays industry.

  • The rising incidence of chronic diseases related to the liver, kidneys, and blood have raised concerns across the medical industry. Several new diagnostic technologies have been developed across the medical industry. Amongst these technologies, immunoassays continue to be the most sought-after means of conducting medical tests.
  • Use of the right reagents and dilution methods while engaging immunoassay analyzers has also gained popularity in recent times. The quest of the medical industry to complete diagnostic tests at palpable speeds and with deft accuracy shall bring automated immunoassay analyzers under the spotlight of attention.
  • The Food and Drug Administration (FDA) has played an integral role in driving sales across the global automated immunoassay analyzers market. The FDA is also responsible for authenticating protein analyzers. The aforementioned trends are suggestive of the inflow of fresh revenues into the global automated immunoassay analyzers market. Some of the common applications of immunoassays span into drug monitoring, allergy testing, cardiac analysis, and infection diagnosis.

Investments made by the medical industry towards diagnosis and diseases analysis has created new pathways for market expansion. Therefore, the revenues index of the global automated immunoassay analyzers market is projected to rise by leaps and bounds

Global Automated Immunoassay Analyzers Market: Snapshot

Immunoassay is a technique or method to detect presence of a particular substance in the human body may be an antigen, antibody, pathogen, hormone, or an enzyme. Immunoassay is based on the principle of antigen and antibody specificity. Immunoassays have been in use in the field of clinical chemistry from a long time. They are being widely used owing to their specificity and rapid test time. Beside clinical diagnostic, immunoassays are being widely used in field of research and development and quality control in pharmaceutical & biotechnology and food & beverages industry. Technological advancements, increasing test volume and shortfall of skilled workforce has led to development of automated immunoassay analyzers. These system perform all the procedures indigenously such as sample preparation, reagent and assay mixing, washing & rinsing, signal detection and result generation.

Aging population, increasing incidences of infectious disease epidemics such as Zica disease, hepatitis infection, HIV and others is likely to drive expansion of automated immunoassay analyzers market during the forecast period from 2017 to 2025. Trend of laboratory consolidation and preventive health care is augmenting the rise in test volume which is leading to demand for laboratory automation and integration. Moreover, demand for international standardization and result comparability is fueling this demand across the globe. Automated immunoassay analyzer is a capital equipment which attract high cost and quality infrastructure. Cost constraint among diagnostic laboratories in developed markets due to declining re-imbursements is likely to hamper the growth of global automated immunoassay analyzers market.

global automated immunoassay analyzers market

Demand for Chemiluminescence Immunoassay to Rise Significantly in Near Future

Based on technology, the global automated immunoassay analyzers market is segmented into chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and others. The CLIA analyzers segment is estimated to account for a leading share of global automated immunoassay analyzers market and register an exponential growth during the forecast period. The others segment which include technologies such as biochip assay, counting immunoassay, immunofluorescent assay (IFA) is estimated to have moderate growth rate from 2017 to 2025.

On the basis of sales model, the global automated immunoassay analyzers market is divided into reagent rental or lease and outright sale segment. The outright sale segment is projected to register highest CAGR during 2017-2025, owing to the increasing focus of key players on this sales model to enhance their cash flows and avoid recurring cost on services and maintenance. Based on end-user, the global market is segmented into hospitals, diagnostic laboratories, blood banks and others. The diagnostic laboratories is segment is estimated to account for leading share of the market and register highest CAGR during the forecast period from 2017 to 2025.

Demand from North America to Significantly Contribute to Overall Market’s Growth

Geographically, global automated immunoassay analyzers market is divided into five major regions, which are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global automated immunoassay analyzers market in terms of value in 2016. The region is estimated to remain dominant during the forecast period, due to strategic presence of key manufacturers. High adoption of technology in the U.S., and rising demand for clinically efficient immunoassay analyzers are the major factors for the estimated growth of venous stents in North America by 2025. However, Asia Pacific is likely to grow with relatively significant CAGR during 2017-2025, due to rising investment by public & private players for the betterment of healthcare services in Asia Pacific region.

Globally, major players operating in the development, manufacturing, and commercialization of automated immunoassay analyzers are Siemens Healthineers, Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Ortho Clinical Diagnostics, Radiometer APS, Randox Laboratories, F. Hoffmann-La Roche Ltd., DiaSorin S.p.A., SNIBE Diagnostics, Sysmex Corporation and Thermo Fisher Scientific.

The Global Automated Immunoassay Analyzers Market has been segmented as given below:

by Technology

  • Chemiluminescence Immunoassay (CLIA)
  • Enzyme Linked Fluorescent Immunoassay (ELFA)
  • Enzyme linked Immunosorbent Assay (ELISA)
  • Radioimmunoassay (RIA)
  • Others (Biochip Assay, Immunofluorescent Assay and Counting Assay)

by Sales Model

  • Reagent Rental / Lease
  • Outright Sale

by End User

  • Hospitals
  • Diagnostic Laboratories
  • Blood Banks
  • Others (Research Institutes, Pharmaceutical & Biotechnology Industry, Food & Beverages Industry)

by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Israel
    • Rest of Middle East & Africa

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Automated Immunoassay Analyzers Market 

4. Market Overview
     4.1. Introduction
            4.1.1. Product Definition
     4.1.2. Industry Evolution / Developments
     4.2. Market Overview
     4.3. Market Dynamics
            4.3.1. Drivers
                     4.3.1.1. Development of new assays and expanding applications areas
                     4.3.1.2. High prevalence and increasing incidences of chronic and infectious diseases
                     4.3.1.3. Laboratory Consolidation and Demand for Laboratory Integration & Automation
                     4.3.1.4. Increasing demand for international accreditations and result comparability
            4.3.2. Restraints
                     4.3.2.1. Promising alternative diagnostic technologies
                     4.3.2.2. Constraint on Laboratories to Reduce Operation and Capital Expenses
            4.3.3. Opportunities
            4.3.4. Trends
     4.4. Automated Immunoassay Analyzers Market Analysis and Forecast, 2017 – 2025
            4.4.1. Market Revenue Projections (US$ Mn)
            4.4.2. Market Volume Projections (Units)
     4.5. Porter’s Five Forces Analysis
     4.6. Strategies Adopted by Top 3 Players
     4.7. Market Outlook

5. Global Automated Immunoassay Analyzers Market Analysis and Forecasts, By Technology 
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Key Trends
     5.4. Market Value (US$ Mn) and Volume (Units)Forecast, By Technology 
            5.4.1. Chemiluminescence Immunoassay (CLIA)
            5.4.2. Enzyme Linked Fluorescent Immunoassay (ELFA)
            5.4.3. Enzyme Linked Immunosorbent Assay (ELISA)
            5.4.4. Radioimmunoassay (RIA)
            5.4.5. Others
     5.5. Market Attractiveness, By Technology 

6. Global Automated Immunoassay Analyzers Market Analysis and Forecasts, By Sales Model
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Market Value (US$ Mn) and Volume (Units) Forecast, By Sales Model
            6.3.1. Reagent Rental / Lease
            6.3.2. Outright Sale
     6.4. Market Attractiveness, By Sales Model

7. Global Automated Immunoassay Analyzers Market Analysis and Forecasts, By End-User
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Market Value (US$ Mn) and Volume (Units) Forecast, By End-User
            7.3.1. Hospitals
            7.3.2. Diagnostic Laboratories
            7.3.3. Blood Banks
            7.3.4. Others
     7.4. Market Attractiveness, By End-User

8. Global Recombinant Automated Immunoassay Analyzers Market Analysis and Forecasts, By Region
     8.1. Key Findings
     8.2. Key Trends, by Region
     8.3. Market Value (US$ Mn) and Volume (Units) Forecast, By Region
            8.3.1. North America
            8.3.2. Europe
            8.3.3. Asia Pacific 
            8.3.4. Latin America
            8.3.5. Middle East and Africa
     8.4. Market Attractiveness, By Region

9. North America Automated Immunoassay Analyzers Market Analysis and Forecast
     9.1. Key Findings
     9.2. Market Value (US$ Mn) and Volume (Units)Forecast, By Technology 
            9.2.1. Chemiluminescence Immunoassay (CLIA)
            9.2.2. Enzyme Linked Fluorescent Immunoassay (ELFA)
            9.2.3. Enzyme Linked Immunosorbent Assay (ELISA)
            9.2.4. Radioimmunoassay (RIA)
            9.2.5. Others
     9.3. Market Value (US$ Mn) and Volume (Units) Forecast, By Sales Model
            9.3.1. Reagent Rental / Lease
            9.3.2. Outright Sale
     9.4. Market Value (US$ Mn) and Volume (Units) Forecast, By End-User
            9.4.1. Hospitals
            9.4.2. Diagnostic Laboratories
            9.4.3. Blood Banks
            9.4.4. Others
     9.5. Market Size by Value (US$ Mn) & Volume (Units) Forecast, By Country
            9.5.1. U.S.
            9.5.2. Canada
     9.6. Market Attractiveness Analysis 
            9.6.1. By Technology
            9.6.2. By Sales Model
            9.6.3. By End-User
            9.6.4. By Country

10.  Europe Automated Immunoassay Analyzers Market Analysis and Forecast
     10.1. Key Findings
     10.2. Market Value (US$ Mn) and Volume (Units)Forecast, By Technology 
            10.2.1. Chemiluminescence Immunoassay (CLIA)
            10.2.2. Enzyme Linked Fluorescent Immunoassay (ELFA)
            10.2.3. Enzyme Linked Immunosorbent Assay (ELISA)
            10.2.4. Radioimmunoassay (RIA)
            10.2.5. Others
     10.3. Market Value (US$ Mn) and Volume (Units) Forecast, By Sales Model
            10.3.1. Reagent Rental / Lease
            10.3.2. Outright Sale
     10.4. Market Value (US$ Mn) and Volume (Units) Forecast, By End-User
            10.4.1. Hospitals
            10.4.2. Diagnostic Laboratories
            10.4.3. Blood Banks
            10.4.4. Others
     10.5. Market Size by Value (US$ Mn) & Volume (Units) Forecast, By Country
            10.5.1. Germany
            10.5.2. Italy
            10.5.3. France
            10.5.4. U.K.
            10.5.5. Spain
            10.5.6. Rest of Europe
     10.6. Market Attractiveness Analysis 
            10.6.1. By Technology
            10.6.2. By Sales Model
            10.6.3. By End-User
            10.6.4. By Country

11.  Asia Pacific Automated Immunoassay Analyzers Market Analysis and Forecast
     11.1. Key Findings
     11.2. Market Value (US$ Mn) and Volume (Units)Forecast, By Technology 
            11.2.1. Chemiluminescence Immunoassay (CLIA)
            11.2.2. Enzyme Linked Fluorescent Immunoassay (ELFA)
            11.2.3. Enzyme Linked Immunosorbent Assay (ELISA)
            11.2.4. Radioimmunoassay (RIA)
            11.2.5. Others
     11.3. Market Value (US$ Mn) and Volume (Units) Forecast, By Sales Model
            11.3.1. Reagent Rental / Lease
            11.3.2. Outright Sale
     11.4. Market Value (US$ Mn) and Volume (Units) Forecast, By End-User
            11.4.1. Hospitals
            11.4.2. Diagnostic Laboratories
            11.4.3. Blood Banks
            11.4.4. Others
     11.5. Market Size by Value (US$ Mn) & Volume (Units) Forecast, By Country
            11.5.1. Japan
            11.5.2. China
            11.5.3. India
            11.5.4. Australia & New Zealand
            11.5.5. Rest of Asia Pacific
     11.6. Market Attractiveness Analysis 
            11.6.1. By Technology
            11.6.2. By Sales Model
            11.6.3. By End-User
            11.6.4. By Country

12.  Latin America Automated Immunoassay Analyzers Market Analysis and Forecast
     12.1. Key Findings
     12.2. Market Value (US$ Mn) and Volume (Units)Forecast, By Technology 
            12.2.1. Chemiluminescence Immunoassay (CLIA)
            12.2.2. Enzyme Linked Fluorescent Immunoassay (ELFA)
            12.2.3. Enzyme Linked Immunosorbent Assay (ELISA)
            12.2.4. Radioimmunoassay (RIA)
            12.2.5. Others
     12.3. Market Value (US$ Mn) and Volume (Units) Forecast, By Sales Model
            12.3.1. Reagent Rental / Lease
            12.3.2. Outright Sale
     12.4. Market Value (US$ Mn) and Volume (Units) Forecast, By End-User
            12.4.1. Hospitals
            12.4.2. Diagnostic Laboratories
            12.4.3. Blood Banks
            12.4.4. Others
     12.5. Market Size by Value (US$ Mn) & Volume (Units) Forecast, By Country
            12.5.1. Brazil
            12.5.2. Mexico
            12.5.3. Rest of Latin America
     12.6. Market Attractiveness Analysis 
            12.6.1. By Technology
            12.6.2. By Sales Model
            12.6.3. By End-User
            12.6.4. By Country

13.  Middle East & Africa Automated Immunoassay Analyzers Market Analysis and Forecast
     13.1. Key Findings
     13.2. Market Value (US$ Mn) and Volume (Units)Forecast, By Technology 
            13.2.1. Chemiluminescence Immunoassay (CLIA)
            13.2.2. Enzyme Linked Fluorescent Immunoassay (ELFA)
            13.2.3. Enzyme Linked Immunosorbent Assay (ELISA)
            13.2.4. Radioimmunoassay (RIA)
            13.2.5. Others
     13.3. Market Value (US$ Mn) and Volume (Units) Forecast, By Sales Model
            13.3.1. Reagent Rental / Lease
            13.3.2. Outright Sale
     13.4. Market Value (US$ Mn) and Volume (Units) Forecast, By End-User
            13.4.1. Hospitals
            13.4.2. Diagnostic Laboratories
                        13.4.3. Blood Banks
            13.4.4. Others
     13.5. Market Size by Value (US$ Mn) & Volume (Units) Forecast, By Country
            13.5.1. GCC Countries
            13.5.2. South Africa
            13.5.3. Israel
            13.5.4. Rest of Middle East & Africa
     13.6. Market Attractiveness Analysis 
            13.6.1. By Technology
            13.6.2. By Sales Model
            13.6.3. By End-User
            13.6.4. By Country

14. Competition Landscape
     14.1.Market Player – Competition Matrix (By Tier and Size of companies)
     14.2.Market Share Analysis By Company (2016)
     14.3.Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
            14.3.1. Siemens Healthineers
                     14.3.1.1. Overview
                     14.3.1.2. Financials
                     14.3.1.3. Recent Developments
                     14.3.1.4. SWOT Analysis
                     14.3.1.5. Strategic Overview
            14.3.2. Abbott Laboratories
                     14.3.2.1. Overview
                     14.3.2.2. Financials
                     14.3.2.3. Recent Developments
                     14.3.2.4. SWOT Analysis
                     14.3.2.5. Strategic Overview
            14.3.3. bioMérieux SA
                     14.3.3.1. Overview
                     14.3.3.2. Financials
                     14.3.3.3. Recent Developments
                     14.3.3.4. SWOT Analysis
                     14.3.3.5. Strategic Overview
            14.3.4. Bio-Rad Laboratories, Inc.
                     14.3.4.1. Overview
                     14.3.4.2. Financials
                     14.3.4.3. Recent Developments
                     14.3.4.4. SWOT Analysis
                     14.3.4.5. Strategic Overview 
            14.3.5. Beckman Coulter, Inc. (Part of Danaher Corporation)
                     14.3.5.1. Overview
                     14.3.5.2. Financials
                     14.3.5.3. Recent Developments
                     14.3.5.4. SWOT Analysis
                     14.3.5.5. Strategic Overview
            14.3.6. Ortho Clinical Diagnostics
                     14.3.6.1. Overview
                     14.3.6.2. Financials
                     14.3.6.3. Recent Developments
                     14.3.6.4. SWOT Analysis
                     14.3.6.5. Strategic Overview 
            14.3.7. Radiometer APS (Part of Danaher Corporation)
                     14.3.7.1. Overview
                     14.3.7.2. Financials
                     14.3.7.3. Recent Developments
                     14.3.7.4. SWOT Analysis
                     14.3.7.5. Strategic Overview
            14.3.8. Randox Laboratories
                     14.3.8.1. Overview
                     14.3.8.2. Financials
                     14.3.8.3. Recent Developments
                     14.3.8.4. SWOT Analysis
                     14.3.8.5. Strategic Overview
            14.3.9. F. Hoffmann-La Roche Ltd.
                     14.3.9.1. Overview
                     14.3.9.2. Financials
                     14.3.9.3. Recent Developments
                     14.3.9.4. SWOT Analysis
                     14.3.9.5. Strategic Overview
            14.3.10. DiaSorin S.p.A.
                     14.3.10.1. Overview
                     14.3.10.2. Financials
                     14.3.10.3. Recent Developments
                     14.3.10.4. SWOT Analysis
                     14.3.10.5. Strategic Overview
            14.3.11. SNIBE Diagnostics
                     14.3.11.1. Overview
                     14.3.11.2. Financials
                     14.3.11.3. Recent Developments
                     14.3.11.4. SWOT Analysis
                     14.3.11.5. Strategic Overview
                                 14.3.12. Sysmex Corporation
                     14.3.12.1. Overview
                     14.3.12.2. Financials
                     14.3.12.3. Recent Developments
                     14.3.12.4. SWOT Analysis
                     14.3.12.5. Strategic Overview
            14.3.13. Thermo Fisher Scientific
                     14.3.13.1. Overview
                     14.3.13.2. Financials
                     14.3.13.3. Recent Developments
                     14.3.13.4. SWOT Analysis
                     14.3.13.5. Strategic Overview

List of Tables

Table 01: Global automated immunoassay analyzers Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 02: Global automated immunoassay analyzers Market Volume (number of units) Forecast, by Technology, 2015–2025
Table 03: Global Automated Immunoassay Analyzers Market Size (US$ Mn) Forecast, by Sales Model, 2015–2025
Table 04: Global Automated Immunoassay Analyzers Market Volume (Units) Forecast, by Sales Model, 2015–2025
Table 05: Global Automated Immunoassay Analyzers Market Size (US$ Mn) Forecast, by End-User, 2015–2025
Table 06: Global Automated Immunoassay Analyzers Market Volume (Units) Forecast, by End-User, 2015–2025
Table 07: Global Automated Immunoassay Analyzers Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 08: Global Automated Immunoassay Analyzers Market Volume (Units) Forecast, by Region, 2015–2025
Table 09: North America Automated Immunoassay Analyzers Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 10: North America Automated Immunoassay Analyzers Market Volume (Units) Forecast, by Technology, 2015–2025
Table 11: North America Automated Immunoassay Analyzers Market Value (US$ Mn) Forecast, by Sales Model, 2015–2025
Table 12: North America Automated Immunoassay Analyzers Market Volume (Units) Forecast, by Sales Model, 2015–2025
Table 13: North America Automated Immunoassay Analyzers Market Value (US$ Mn) Forecast, by End-User, 2015–2025
Table 14: North America Automated Immunoassay Analyzers Market Volume (Units) Forecast, by End-User, 2015–2025
Table 15: North America Automated Immunoassay Analyzers Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 16: North America Automated Immunoassay Analyzers Market Volume (Units) Forecast, by Country, 2015–2025
Table 17: Europe Automated Immunoassay Analyzers Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 18: Europe Automated Immunoassay Analyzers Market Volume (Units) Forecast, by Technology, 2015–2025
Table 19: Europe Automated Immunoassay Analyzers Market Value (US$ Mn) Forecast, by Sales Model, 2015–2025
Table 20: Europe Automated Immunoassay Analyzers Market Volume (Units) Forecast, by Sales Model, 2015–2025
Table 21: Europe Automated Immunoassay Analyzers Market Value (US$ Mn) Forecast, by End-User, 2015–2025
Table 22: Europe Automated Immunoassay Analyzers Market Volume (Units) Forecast, by End-User, 2015–2025
Table 23: Europe Automated Immunoassay Analyzers Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 24: Europe Automated Immunoassay Analyzers Market Volume (Units) Forecast, by Country, 2015–2025
Table 25: Asia Pacific Automated Immunoassay Analyzers Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 26: Asia Pacific Automated Immunoassay Analyzers Market Volume (Units) Forecast, by Technology, 2015–2025
Table 27: Asia Pacific Automated Immunoassay Analyzers Market Value (US$ Mn) Forecast, by Sales Model, 2015–2025
Table 28: Asia Pacific Automated Immunoassay Analyzers Market Volume (Units) Forecast, by Sales Model, 2015–2025
Table 29: Asia Pacific Automated Immunoassay Analyzers Market Value (US$ Mn) Forecast, by End-User, 2015–2025
Table 30: Asia Pacific Automated Immunoassay Analyzers Market Volume (Units) Forecast, by End-User, 2015–2025
Table 31: Asia Pacific Automated Immunoassay Analyzers Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 32: Asia Pacific Automated Immunoassay Analyzers Market Volume (Units) Forecast, by Country, 2015–2025
Table 33: Latin America Automated Immunoassay Analyzers Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 34: Latin America Automated Immunoassay Analyzers Market Volume (Units) Forecast, by Technology, 2015–2025
Table 35: Latin America Automated Immunoassay Analyzers Market Value (US$ Mn) Forecast, by Sales Model, 2015–2025
Table 36: Latin America Automated Immunoassay Analyzers Market Volume (Units) Forecast, by Sales Model, 2015–2025
Table 37: Latin America Automated Immunoassay Analyzers Market Value (US$ Mn) Forecast, by End-User, 2015–2025
Table 38: Latin America Automated Immunoassay Analyzers Market Volume (Units) Forecast, by End-User, 2015–2025
Table 39: Latin America Automated Immunoassay Analyzers Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 40: Latin America Automated Immunoassay Analyzers Market Volume (Units) Forecast, by Country, 2015–2025
Table 41: Middle East & Africa Automated Immunoassay Analyzers Market Size (US$ Mn) Forecast, by Technology, 2015–2025
Table 42: Middle East & Africa Automated Immunoassay Analyzers Market Volume (Units) Forecast, by Technology, 2015–2025
Table 43: Middle East & Africa Automated Immunoassay Analyzers Market Value (US$ Mn) Forecast, by Sales Model, 2015–2025
Table 44: Middle East & Africa Automated Immunoassay Analyzers Market Volume (Units) Forecast, by Sales Model, 2015–2025
Table 45: Middle East & Africa Automated Immunoassay Analyzers Market Value (US$ Mn) Forecast, by End-User, 2015–2025
Table 46: Middle East & Africa Automated Immunoassay Analyzers Market Volume (Units) Forecast, by End-User, 2015–2025
Table 47: Middle East & Africa Automated Immunoassay Analyzers Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 48: Middle East & Africa Automated Immunoassay Analyzers Market Volume (Units) Forecast, by Country, 2015–2025

List of Figures

Figure 01: Automated Immunoassay Analyzers Market, by Technology, Market Size (US$ Mn) and Volume share (%), 2016 (A)
Figure 02: Automated Immunoassay Analyzers Market Revenue (%), by End-User, 2016 (A)
Figure 03: automated immunoassay analyzers Market Revenue (%), by Region, 2016 (A)
Figure 04: Technology Revenue (%), 2016
Figure 05: Sales Model Revenue (%), 2016
Figure 06: End-User Revenue  (%), 2016
Figure 07: Global automated immunoassay analyzers Market Size (US$ Mn) Forecast, 2015–2025
Figure 08: Market Value Share, by Technology (2016)
Figure 09: Market Value Share, by Sales Model (2016)
Figure 10: Market Value Share, by End-User (2016)
Figure 11: Market Value Share, by Region (2016)
Figure 12: Global Automated Immunoassay Analyzers Market Value Share, by Technology, 2016 and 2025
Figure 13: Global Automated Immunoassay Analyzers Market Attractiveness, by Technology, 2017–2025
Figure 14: Global Automated Immunoassay Analyzers Market Revenue (US$ Mn) and Y-o-Y Growth (%), 
by CLIA, 2015–2025
Figure 15: Global Automated Immunoassay Analyzers Market Revenue (US$ Mn) and Y-o-Y Growth (%), 
by ELFA, 2015–2025
Figure 16: Global Automated Immunoassay Analyzers Market Revenue (US$ Mn) and Y-o-Y Growth (%), 
by ELISA, 2015–2025
Figure 17: Global Automated Immunoassay Analyzers Market Revenue (US$ Mn) and Y-o-Y Growth (%), 
by RIA, 2015–2025
Figure 18: Global Automated Immunoassay Analyzers Market Revenue (US$ Mn) and Y-o-Y Growth (%), 
by Others,2015–2025
Figure 19: Global Automated Immunoassay Analyzers Market Value Share, by Sales Model, 2016 and 2025
Figure 20: Global Automated Immunoassay Analyzers Market Attractiveness, by Sales Model, 2017–2025
Figure 21: Global Automated Immunoassay Analyzers Market Revenue (US$ Mn) And Y-o-y Growth (%), 
By Reagent Rental / Lease, 2015–2025
Figure 22: Global Automated Immunoassay Analyzers Market Revenue (US$ Mn) and y-o-y growth (%), 
by Outright Sale, 2015–2025
Figure 23: Global Automated Immunoassay Analyzers Market Value Share, by End-User, 2016 and 2025
Figure 24: Global Automated Immunoassay Analyzers Market Attractiveness, by End-User, 2017–2025
Figure 25: Global Automated Immunoassay Analyzers Market Revenue (US$ Mn) and Y-o-Y Growth (%),
by Hospitals, 2015–2025
Figure 26: Global Automated Immunoassay Analyzers Market Revenue (US$ Mn) and Y-o-Y Growth (%), 
by Diagnostic Laboratories, 2015–2025
Figure 27: Global Automated Immunoassay Analyzers Market Revenue (US$ Mn) and Y-o-Y Growth (%), 
by Blood Banks, 2015–2025
Figure 28: Global Automated Immunoassay Analyzers Market Revenue (US$ Mn) and Y-o-Y Growth (%), 
by Others, 2015–2025
Figure 29: Global Automated Immunoassay Analyzers Market Value Share, by Region, 2016 and 2025 
Figure 30: Global Automated Immunoassay Analyzers Market Attractiveness, by Region, 2017–2025
Figure 31: North America Automated Immunoassay Analyzers Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2025
Figure 32: North America Automated Immunoassay Analyzers Market Volume (Units) and Y-o-Y Growth (%) Forecast, 2017–2025
Figure 33: North America Automated Immunoassay Analyzers Market Value Share Analysis, by Technology, 2016 and 2025
Figure 34: North America Automated Immunoassay Analyzers Market Value Share Analysis, by Sales Model, 2016 and 2025
Figure 35: North America Automated Immunoassay Analyzers Market Value Share Analysis, by End-User, 2016 and 2025
Figure 36: North America Automated Immunoassay Analyzers Market Value Share Analysis, by Country, 2016 and 2025
Figure 37: North America Automated Immunoassay Analyzers Market Attractiveness Analysis, by Technology
Figure 38: North America Automated Immunoassay Analyzers Market Attractiveness Analysis, by Sales Model
Figure 39: North America Automated Immunoassay Analyzers Market Attractiveness Analysis, by End-User 
Figure 40: North America Automated Immunoassay Analyzers Market Attractiveness Analysis, by Country
Figure 41: Europe Automated Immunoassay Analyzers Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2025
Figure 42: Europe Automated Immunoassay Analyzers Market Volume (Units) and Y-o-Y Growth (%) Forecast, 2017–2025
Figure 43: Europe Automated Immunoassay Analyzers Market Value Share Analysis, by Technology, 2016 and 2025
Figure 44: Europe Automated Immunoassay Analyzers Market Value Share Analysis, by Sales Model, 2016 and 2025
Figure 45: Europe Automated Immunoassay Analyzers Market Value Share Analysis, by End-User, 2016 and 2025
Figure 46: Europe Automated Immunoassay Analyzers Market Value Share Analysis, by Country, 2016 and 2025
Figure 47: Europe Automated Immunoassay Analyzers Market Attractiveness Analysis, by Technology
Figure 48: Europe Automated Immunoassay Analyzers Market Attractiveness Analysis, by Sales Model
Figure 49: Europe Automated Immunoassay Analyzers Market Attractiveness Analysis, by End-User 
Figure 50: Europe Automated Immunoassay Analyzers Market Attractiveness Analysis, by Country
Figure 51: Asia Pacific Automated Immunoassay Analyzers Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2025
Figure 52: Asia Pacific Automated Immunoassay Analyzers Market Volume (Units) and Y-o-Y Growth (%) Forecast, 2017–2025
Figure 53: Asia Pacific Automated Immunoassay Analyzers Market Value Share Analysis, by Technology, 2016 and 2025
Figure 54: Asia Pacific Automated Immunoassay Analyzers Market Value Share Analysis, by Sales Model, 2016 and 2025
Figure 55: Asia Pacific Automated Immunoassay Analyzers Market Value Share Analysis, by End-User, 2016 and 2025
Figure 56: Asia Pacific Automated Immunoassay Analyzers Market Value Share Analysis, by Country, 2016 and 2025
Figure 57: Asia Pacific Automated Immunoassay Analyzers Market Attractiveness Analysis, by Technology
Figure 58: Asia Pacific Automated Immunoassay Analyzers Market Attractiveness Analysis, by Sales Model
Figure 59: Asia Pacific Automated Immunoassay Analyzers Market Attractiveness Analysis, by End-User 
Figure 60: Asia Pacific Automated Immunoassay Analyzers Market Attractiveness Analysis, by Country
Figure 61: Latin America Automated Immunoassay Analyzers Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2025
Figure 61: Latin America Automated Immunoassay Analyzers Market Volume (Units) and Y-o-Y growth (%) Forecast, 2017–2025
Figure 63: Latin America Automated Immunoassay Analyzers Market Value Share Analysis, by Technology, 2016 and 2025
Figure 64: Latin America Automated Immunoassay Analyzers Market Value Share Analysis, by Sales Model, 2016 and 2025
Figure 65: Latin America Automated Immunoassay Analyzers Market Value Share Analysis, by End-User, 2016 and 2025
Figure 66: Latin America Automated Immunoassay Analyzers Market Value Share Analysis, by Country, 2016 and 2025
Figure 67: Latin America Automated Immunoassay Analyzers Market Attractiveness Analysis, by Technology
Figure 68: Latin America Automated Immunoassay Analyzers Market Attractiveness Analysis, by Sales Model
Figure 69: Latin America Automated Immunoassay Analyzers Market Attractiveness Analysis, by End-User 
Figure 70: Latin America Automated Immunoassay Analyzers Market Attractiveness Analysis, by Country
Figure 71: Middle East & Africa Automated Immunoassay Analyzers Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2025
Figure 72: Middle East & Africa Automated Immunoassay Analyzers Market Volume (Units) and Y-o-Y Growth (%) Forecast, 2017–2025
Figure 73: Middle East & Africa Automated Immunoassay Analyzers Market Value Share Analysis, by Technology, 2016 and 2025
Figure 74: Middle East & Africa Automated Immunoassay Analyzers Market Value Share Analysis, by Sales Model, 2016 and 2025
Figure 75: Middle East & Africa Automated Immunoassay Analyzers Market Value Share Analysis, by End-User, 2016 and 2025
Figure 76: Middle East & Africa Automated Immunoassay Analyzers Market Value Share Analysis, by Country, 2016 and 2025
Figure 77: Middle East & Africa Automated Immunoassay Analyzers Market Attractiveness Analysis, by Technology
Figure 78: Middle East & Africa Automated Immunoassay Analyzers Market Attractiveness Analysis, by Sales Model
Figure 79: Middle East & Africa Automated Immunoassay Analyzers Market Attractiveness Analysis, by End-User 
Figure 80: Middle East & Africa Automated Immunoassay Analyzers Market Attractiveness Analysis, by Country
Figure 81: Global Automated Immunoassay Analyzer Market Share Analysis, by Company (2016)

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Automated Immunoassay Analyzers Market